tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AstraZeneca, Daiichi Sankyo dose first patient in DESTINY-Lung06 trial
PremiumThe FlyAstraZeneca, Daiichi Sankyo dose first patient in DESTINY-Lung06 trial
4d ago
AstraZeneca reports gefurulimab met primary endpoint in PREVAIL Phase 3 trial
Premium
The Fly
AstraZeneca reports gefurulimab met primary endpoint in PREVAIL Phase 3 trial
5d ago
AstraZeneca’s New Study on Chronic Kidney Disease: Potential Market Impact
Premium
Company Announcements
AstraZeneca’s New Study on Chronic Kidney Disease: Potential Market Impact
5d ago
AstraZeneca’s Dapagliflozin Study: Real-World Insights on CKD Treatment
PremiumCompany AnnouncementsAstraZeneca’s Dapagliflozin Study: Real-World Insights on CKD Treatment
7d ago
AstraZeneca’s Koselugo approved in EU for plexiform neurofibromas
Premium
The Fly
AstraZeneca’s Koselugo approved in EU for plexiform neurofibromas
7d ago
AstraZeneca’s New Study on NF1 in Egypt: What Investors Need to Know
Premium
Company Announcements
AstraZeneca’s New Study on NF1 in Egypt: What Investors Need to Know
7d ago
AstraZeneca’s New Study: Impact of AZD0780 on Metformin Pharmacokinetics
PremiumCompany AnnouncementsAstraZeneca’s New Study: Impact of AZD0780 on Metformin Pharmacokinetics
7d ago
AstraZeneca’s Osimertinib Study: Key Insights for Investors
Premium
Company Announcements
AstraZeneca’s Osimertinib Study: Key Insights for Investors
8d ago
AstraZeneca and Daiichi Sankyo’s New Study on Dato-DXd: What Investors Need to Know
Premium
Company Announcements
AstraZeneca and Daiichi Sankyo’s New Study on Dato-DXd: What Investors Need to Know
8d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100